Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest ABVD Stories

2009-07-15 09:05:21

U.S. medical scientists say they have developed a new chemotherapy regimen for pediatric Hodgkin's lymphoma patients. Dr. Cindy Schwartz of Brown University Medical School's Hasbro Children's Hospital said the new treatment enhances efficacy through dose-dense drug delivery, while simultaneously reducing the long-term risks presented by high cumulative dose chemotherapy. Schwartz said current therapy for the disease in the United States did not include the most modern treatment models, in...

2009-07-13 15:25:47

New research led by Cindy Schwartz, MD, of Hasbro Children's Hospital has identified a new chemotherapy regimen for pediatric Hodgkin lymphoma (HL) patients. The new treatment enhances efficacy through dose-dense drug delivery while simultaneously reducing the long-term risks presented by high cumulative dose chemotherapy. Schwartz and the researchers of the Children's Oncology Group have published their findings in the journal Blood (posted in an online first edition).The Children's Oncology...

2009-05-25 08:49:20

People undergoing chemotherapy often receive drugs aimed at keeping them from vomiting after the treatments. But the nausea associated with chemotherapy can still linger, making people miserable for days. New research out of the James P. Wilmot Cancer Center in Rochester, NY, finds taking small amounts of ginger prior to and immediately following a chemotherapy treatment can make a big difference. In their study, those who took the supplements for three days before and after the treatments...

2009-04-09 14:27:26

High-dose radiation and chemotherapy in combination can improve lung cancer survival rates, U.S. researchers said. The study, published in the International Journal of Radiation Oncology*Biology*Physics, also finds survival increased by increasing the dose of radiation over the course of treatment. When patients are diagnosed with stage III lung cancer, surgery is often not an option, and survival rates are typically quite low. Finding new ways to improve survival, even in small increments,...

2005-10-07 14:21:13

By Anthony J. Brown, MD NEW YORK (Reuters Health) - Due to the chest radiation that is often given for treatment, women who survive Hodgkin's disease are at heightened risk for breast cancer. In fact, in some survivors, the odds of developing breast cancer are as high as 40 percent, new research indicates. The authors warn, however, that the findings are based on older treatment approaches and, therefore, may not be applicable to women treated today for Hodgkin's disease, a type of...